Abstract

Our study confirmed previous observations suggesting that underlying cardiovascular disease is associated with an increased risk of in-hospital death among patients hospitalized with Covid-19. Our results did not confirm previous concerns regarding a potential harmful association of ACE inhibitors or ARBs with in-hospital death in this clinical context. (Funded by the William Harvey Distinguished Chair in Advanced Cardiovascular Medicine at Brigham and Women's Hospital.).

Keywords

Coronavirus disease 2019 (COVID-19)DiseaseMedicineDrugPharmacotherapyIntensive care medicineVirologyInternal medicinePharmacologyInfectious disease (medical specialty)

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
382
Issue
25
Pages
e102-e102
Citations
1480
Access
Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1480
OpenAlex
70
Influential
658
CrossRef

Cite This

Mandeep R. Mehra, Sapan S. Desai, SreyRam Kuy et al. (2020). Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. New England Journal of Medicine , 382 (25) , e102-e102. https://doi.org/10.1056/nejmoa2007621

Identifiers

DOI
10.1056/nejmoa2007621
PMID
32356626
PMCID
PMC7206931

Data Quality

Data completeness: 81%